Graph Therapeutics Revenue

Biotechnology Research • Vienna, Vienna, Austria • 11-20 Employees

Graph Therapeutics revenue & valuation

Annual revenue	$1,283,325
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,200,000
Total funding	No funding

Key Contact at Graph Therapeutics

Bojan Vilagos

Co-Founder, Cso

Company overview

Headquarters	Vienna, Vienna, Austria
Website	graphtx.com
NAICS	541714
Founded	2024
Employees	11-20
Socials

Graph Therapeutics Email Formats

Graph Therapeutics uses 4 email formats. The most common is {first name} (e.g., john@graphtx.com), used 68.8% of the time.

Format	Example	Percentage
{first name}	john@graphtx.com	68.8%
{first initial}	j@graphtx.com	12.5%
{first initial}.{last name}	j.doe@graphtx.com	12.5%
{first name}.{last name}	john.doe@graphtx.com	6.2%

About Graph Therapeutics

Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of patients are left without adequate treatment options - and AI trained with complex disease data can solve this.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Head

C-Suite

Employees by Department

Graph Therapeutics has 7 employees across 5 departments.

Departments

Number of employees

Funding Data

Graph Therapeutics has never raised funding before.

Graph Therapeutics Tech Stack

Discover the technologies and tools that power Graph Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Apple iCloud Mail

Webmail

Google Workspace

HTTP/3

Miscellaneous

Frequently asked questions

Graph Therapeutics is located in Vienna, Vienna, AT.

Graph Therapeutics generates an estimated annual revenue of $1,283,325. This revenue figure reflects the company's market position and business performance in its industry.

Graph Therapeutics has an estimated valuation of $4,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Graph Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Graph Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Graph Therapeutics

Bojan Vilagos

Co-Founder, Cso

4.8

40,000 users